---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014674"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T14:02:33.594730+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biofrontera confirms talks with Biofrontera AG on merger or license restructuring

## Summary
- Negotiations with Biofrontera AG include possible combination of the two companies.
- Alternative: adjustment to license/supply agreement transferring certain rights to Biofrontera Inc.
- Potential reduction in transfer price for licensed products sold in the US.
- Terms not yet established; subject to definitive agreements and conditions.
- Disclosure follows June 10, 2025 announcement by Biofrontera AG's management board.

## SEC filing metadata
- accession: 0001641172-25-014674
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000164117225014674/0001641172-25-014674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000164117225014674/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014674
- JSON: https://secwatch.observer/filing/0001641172-25-014674.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014674.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.